2 options
GlaxoSmithKline and developing country access to essential medicines (A) / N. Craig Smith, Anne Duncan.
Connect to full text Available online
View online- Format:
- Book
- Author/Creator:
- Smith, N. Craig, 1958- author.
- Duncan, Anne, author.
- Series:
- SAGE Knowledge. Cases.
- SAGE Knowledge. Cases
- Language:
- English
- Subjects (All):
- Drug accessibility.
- GlaxoSmithKline.
- Pharmaceutical industry.
- Physical Description:
- 1 online resource : illustrations.
- Place of Publication:
- London : NeilsonJournals Publishing, 2005.
- System Details:
- text file
- Summary:
- The merger of GlaxoWellcome and SmithKlineBeecham in 2000 created the world's second largest pharmaceutical company, GlaxoSmithKline. GSK also became the world's leader in the provision of drugs to treat the three most critical diseases in the developing world: HIV/AIDS, malaria and tuberculosis. In addition to merger related strategy and restructuring activities, the company finds itself having to respond to pressures to increase access to these essential medicines in developing countries, including the possibility of major reductions in price. How should GSK respond to these pressures?
- Notes:
- Originally Published InSmith, N. C., & Duncan, A. (2005). GlaxoSmithKline and developing country access to essential medicines (A). Journal of Business Ethics Education, 2(1), 97-122. JBEE2-1CS1.
- Includes bibliographical references and index.
- No ILL or scholarly sharing allowed.
- Description based on XML content.
- ISBN:
- 9781526460653
- OCLC:
- 1089145237
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.